IMF Videos Search Content For Healthcare Professional (96) Healthcare Provider (96) Series - Any - About the IMF (2) ASCO/EHA (71) ASH (102) Ask Dr. Durie (149) Black Swan Research Initiative (7) Community Workshops (5) Emerging Therapies (18) Facebook Live (21) Health Equity (14) IMF History (3) IMWG (12) Inspirational (15) Living Well with Myeloma (33) Myeloma in a Minute (25) Myeloma Made Simple (15) Myeloma University (12) NLB Webcasts (1) Patient & Family Webinar (11) Q&A (22) Recent News and Developments (5) Treatments (3) Trending Searches in Myeloma (4) Topics Clinical Trials (60) Financial Considerations (1) Frontline Therapy (10) Health Equity (8) Inspirational Stories (1) Lab & Imaging Tests (14) Recorded Webinars (1) Relapse/Refractory Myeloma (30) Research Updates (69) Symptom Management (4) Myeloma Stage Early Relapse (1–3 Lines of Therapy) (15) High-Risk Myeloma (12) High-risk Smoldering Myeloma (7) Late Relapse (4–6 Lines of Therapy) (25) MGUS (16) Newly Diagnosed (Pre-Treatment or First Treatment) (19) Smoldering Myeloma (15) Types of Therapy Immunomodulatory drugs (IMiDs) (18) Immunotherapies (CAR T; BiTE, etc.) (27) Monoclonal antibodies (12) Proteasome inhibitors (14) Stem cell transplant (13) Steroids (10) Supportive Care (8) Year Published 2026 (7) 2025 (23) 2024 (22) 2023 (19) 2022 (13) 2021 (7) 2020 (1) 2019 (8) 2018 (1) 2016 (1) Trusted Voices Dr. María-Victoria Mateos (6) Dr. Shaji Kumar (2) Dr. Joseph Mikhael (1) Dr. Saad Usmani (1) Dr. Sigurður Kristinsson (1) Sort Newest firstOldest firstA -> ZZ -> ARelevance Curative Strategy (GEM-CESAR) for High-Risk Smoldering Myeloma (SMM) December 11, 2019 ASH Safety and Efficacy of Venetoclax in Combination with Dexamethasone As Targeted Therapy for Patients with t(11;14) Relapsed/Refractory Multiple Myeloma December 10, 2019 ASH Outcomes in Multiple Myeloma Based on Comorbidities and Race December 9, 2019 ASH Evaluation of Upfront Therapy for the ASCT-Ineligible Patient December 7, 2019 ASH Curative Strategy for High-Risk Smoldering Myeloma (GEM-CESAR) January 3, 2018 ASH Treatment Advances in Multiple Myeloma: Expert Perspectives on Translating Clinical Data to Practice November 16, 2016 ASH
